180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
It has been a busy and productive few months here at 180 Life Sciences.
- It has been a busy and productive few months here at 180 Life Sciences.
- This was in collaboration with Prof. SirMarc Feldmann, one of the founders of 180 Life Sciences and current Co-Chairman of our Board of Directors.
- Sir Marc is intimately involved in the development of 2 of the 3 projects being developed by 180 Life Sciences, new uses of anti-TNF and synthetic cannabidiol analogues.
- 180 Life Sciences is leading the research into solving one of the worlds biggest drivers of disease inflammation.